June 21, 2024

Vir Biotechnology Inc., a publicly traded firm seeking to develop treatments for infectious diseases, said Wednesday it is closing its St. Louis office in the Cortex innovation district as part of a wider cost-cutting initiative.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *